Purification of Vero cell derived live replication deficient influenza A and B virus by ion exchange monolith chromatography

Vaccine

Volumn 32, Issue 21, 2014, Pages 2487-2492

  Banjac, Marko ^a   Roethl, Elisabeth ^b   Gelhart, Franz ^b   Kramberger, Petra ^a   Jarc, Barbara Lah ^a   Jarc, Marko ^a   Štrancar, Aleš ^a   Muster, Thomas ^b   Peterka, Matjaž ^a  

^a BIA SEPARATIONS D O O   (Slovenia)

^b Avir Green Hills Biotechnology AG   (Austria)

Author keywords

Chromatography; Influenza viruses; Monoliths; Purification; Vaccines

Indexed keywords

DEOXYRIBONUCLEASE; INFLUENZA VACCINE; METHACRYLIC ACID; NONSTRUCTURAL PROTEIN 1;

ANION EXCHANGE; ARTICLE; CATION EXCHANGE; DNA CONTENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST CELL; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS B; ION EXCHANGE CHROMATOGRAPHY; ION EXCHANGE MONOLITH CHROMATOGRAPHY; NONHUMAN; PH; PRIORITY JOURNAL; REPRODUCIBILITY; SCALE UP; VERO CELL; VIRUS ATTACHMENT; VIRUS HEMAGGLUTINATION; VIRUS INFECTIVITY; VIRUS PURIFICATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

CHROMATOGRAPHY; INFLUENZA VIRUSES; MONOLITHS; PURIFICATION; VACCINES;

ADSORPTION; ANIMALS; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, ION EXCHANGE; FILTRATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA B VIRUS; VERO CELLS; VIRUS CULTIVATION; VIRUS REPLICATION;

EID: 84898481547     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.086     Document Type: Article

References (37)

1. Acute respiratory Infections. http://www.who.int/vaccine_research/diseases/ari/en/.
2. Fodor E., Brownlee G.G. Influenza virus replication. Influenza (perspectives in medical virology) 2002, 1-30. Elsevier, Amsterdam. C.W. Potter (Ed.).
3. Pau M.G., Ophorst C., Koldijk M.H., Schouten G., Mehtali M., et al. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 2001, 19:2716-2721.
4. Kistner O., Barret P.N., Mundt W., Reiter M., Schober-Bendixen S., et al. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 1998, 16:960-968.
5. Voeten J.T., Brands R., Palache A.M., van Scharrenburg G.J., Rimmelzwaan G.F., et al. Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium. Vaccine 1999, 17:1942-1950.
6. Mischler R., Metcalf I.C. Inflexal V a trivalent virosome subunit influenza vaccine: production. Vaccine 2002, 20:B17-B23.
7. Pepper D.S. A chromatographic procedure for the purification of influenza virus. J Gen Virol 1967, 1:49-55.
8. Wallis C., Homma A., Melnic J.L. Concentration and purification of influenza virus on insoluble polyelectrolytes. Appl Microbiol 1972, 23:740-744.
9. Heyward J.T., Klinas R.A., Stapp M.D., Obijeski J.F. The rapid concentration and purification of influenza virus from allantoic fluid. Arch Virol 1977, 55:107-119.
10. Sagar M.G., Hanssen H., Gerba C.P. Simple method for the concentration of influenza virus from allantoic fluid on microporous filters. Appl Environ Microbiol 1980, 39:500-504.
11. Nayak D.P., Lehmann S., Reichl U. Downstream processing of MDCK cell-derived equine influenza virus. J Chromatogr B 2005, 823:75-81.
12. Kalbfuss B., Wolff M., Morenweiser R., Reichl U. Purification of cell culture derived human influenza A virus by size exclusion and anion exchange chromatography. Biotech Bioeng 2007, 96:932-944.
13. Kramberger P., Peterka M., Boben J., Ravnikar M., Štrancar A. Short monolithic columns-a breakthrough in purification and fast quantification of tomato mosaic virus. J Chromatogr A 2007, 1144:143-149.
14. Vicente T., Sousa M.F.Q., Peixoto C., Mota J.P.B., Alves P.M., et al. Anion-exchange membrane chromatography for purification of rotavirus-like particles. J Memb Sci 2008, 311:270-283.
15. Kalbfuss B., Wolff M., Geisler L., Tappe A., Wickramasinghe R., et al. Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers. J Memb Sci 2007, 299:251-260.
16. Opitz L., Salaklang J., Buttner H., Reichl U., Wollf M. Lectin affinity chromatography for downs team processing of MDCK cell culture derived human influenza A viruses. Vaccine 2007, 25:939-947.
17. Kalashnikova N., Ivanova T., Tennikova Development of a strategy of influenza virus separation based on pseudoaffinity chromatography on short monolithic columns. Anal Chem 2008, 80:2188-2198.
18. Opitz L., Lehmann S., Reichl U., Wolff M.W. Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles. Biotechnol Bioeng 2009, 103:1144-1154.
19. Egorov A., Brandt S., Sereinig S., Romanova J., Ferko B., et al. Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol 1998, 72:6437-6441.
20. García-Sastre A., Egorov A., Matassov D., Brandt S., Levy D.E., et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 1998, 252:324-330.
21. Romanova J., Krenn B.M., Wolschek M., Ferko B., Romanovskaja-Romanko E., et al. Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine. PLoS One 2009, 4(6):e5984.
22. Talon J., Salvatore M., Re O.N., Nakaya Y., Zheng H., et al. Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. PNAS 2000, 97:4309-4314.
23. Donelan N.R., Basler C.F., Garcia-Sastre A. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 2003, 77:13257-13266.
24. Talon J., Horvath C.M., Polley R., Basler F.C., Muster T., et al. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 2000, 74:7989-7996.
25. Ferko B., Stasakova J., Romanova J., Kittel C., Sereinig S., et al. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol 2004, 78:13037-13045.
26. Wachek V., Egorov A., Groiss F., Pfeiffer A., Fuereder T., et al. A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J Infect Dis 2010, 201:354-362.
27. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. PNAS 2000, 97:6108-6113.
28. Roethl E., Gassner M., Krenn B.M., Romanovskaya-Romanko E.A., Seper H., et al. Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture. J Virol 2011, 85:11139-11145.
29. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938, 27:493-497.
30. Neurath A.R., Rubin B.A., Pierzchala W.A. Importance of the ionic form of ion exchangers for chromatography of macromolecular substances: purification of influenza viruses. Arch Biochem Biophys 1967, 120:238-239.
31. Helenius A. Unpacking the incoming influenza virus. Cell 1992, 69:577-578.
32. Lendero N., Vidič J., Brne P., Frankovič V., Štrancar A., et al. Characterization of ion exchange stationary phases via pH transition profiles. J Chromatogr A 2008, 1185:59-70.
33. Miller G.L. Influence of pH and of certain other conditions on the stability of the infectivity and red agglutinating activity of influenza virus. J Exp Med 1944, 80(6):507-520.
34. Oster G. The isoelectric points of some strains of tobacco mosaic virus. J Biol Chem 1951, 190:55-59.
35. Yamamoto S., Ishihara T. Ion-exchange chromatography of proteins near the isoelectric points. J Chromatogr A 1999, 852:31-36.
36. Rimmelzwaan G.F., Baars M., Claas E.C.J., Osterhaus A.D.M.E. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods 1998, 74:57-66.
37. Bencina M., Podgornik A., Strancar A. Characterization of methacrylate monoliths for purification of DNA molecules. J Sep Sci 2004, 27:801-810.